Anandamide- and Δ9-tetrahydrocannabinol-evoked arachidonic acid mobilization and blockade by SR141716A [N-(piperidin-1-yl)-5-(4-chlorophenyl)-1-(2,4-dichloro-phenyl)-4-methyl-1H-Pyrazole-3-carboximide hydrochloride]
- 1 March 1996
- journal article
- Published by Elsevier in Biochemical Pharmacology
- Vol. 51 (5) , 669-676
- https://doi.org/10.1016/s0006-2952(95)02248-1
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- The MAP kinase signal transduction pathway is activated by the endogenous cannabinoid anandamideFEBS Letters, 1995
- Phospholipase participation in cannabinoid-induced release of free arachidonic acidBiochemical Pharmacology, 1994
- Anandamide, a Brain Endogenous Compound, Interacts Specifically with Cannabinoid Receptors and Inhibits Adenylate CyclaseJournal of Neurochemistry, 1993
- Pharmacological activity of the cannabinoid receptor agonist, anandamide, a brain constituentEuropean Journal of Pharmacology, 1993
- Isolation and Structure of a Brain Constituent That Binds to the Cannabinoid ReceptorScience, 1992
- G-protein mediation of cannabinoid-induced phospholipase activationPharmacology Biochemistry and Behavior, 1991
- The cannabinoid receptor: biochemical, anatomical and behavioral characterizationTrends in Neurosciences, 1990
- Prostaglandins and Cannabis—VIII. Elevation of Phospholipase A2 Activity by Cannabinoids in Whole Cells and Subcellular PreparationsThe Journal of Clinical Pharmacology, 1981
- Effects of Δ9-tetrahydrocannabinol and cannabidiol on phospholipase and other enzymes regulating arachidonate metabolismProstaglandins and Medicine, 1980
- Prostaglandins and cannabis—VIBiochemical Pharmacology, 1978